[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"CHFDX,Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100619910","observational-study-designed-to-detect-decompensation-of-congestive-heart-failure-dchf-using-a-non-invasive-wearable-device-100619910",false,"NCT07350759","Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device","An Observational Study to Develop an Algorithm to Predict Decompensation of Congestive Heart Failure (dCHF) Using a Non-Invasive Wearable Device.","Inclusion Criteria:\n\n* • Age ≥ 18 years\n\n  * Current use of a hemodynamic sensoring device\n  * At least 4 consecutive weeks of stabilized \"goal\" pulmonary artery pressures\n  * Access to a personal smartphone with Wi-Fi or cellular connectivity\n\nExclusion Criteria:\n\n* • Inability to provide informed consent\n\n  * Inability to read or understand English\n  * Likely non-adherence to wearable device use\n  * Prisoners\n  * Pregnant females","ALL","18 Years",{"count":19,"type":20},60,"ESTIMATED","1 Year","OBSERVATIONAL","This is a prospective, observational pilot study designed to develop a mathematical algorithm capable of predicting decompensation of congestive heart failure (dCHF) using physiologic data collected from a non-invasive wearable device. Participants with a remote hemodynamic pulmonary artery pressure monitor will wear a wearable device continuously for up to 12 months. Wearable data will be analyzed in relation to the hemodynamic monitor defined sentinel events of heart failure decompensation to identify predictive signal patterns. Optional biospecimen (DNA, blood, urine) and voice sample collection will support future biomarker discovery.",[25],"Decompensated Chronic Heart Failure",[27,28,29],"congestive heart failure","wearable monitor","predictive algrothim","RECRUITING","2026-03-09",{"date":33,"type":34},"2026-03-11","ACTUAL",{"date":31,"type":34},{"date":37,"type":20},"2026-12-31",{"name":39,"class":40},"CHFDX,Inc.","INDUSTRY",2,""]